Shockwave treatment for advanced angina in Maastricht (SWAAM). A double blind randomised study.

Shockwave treatment for advanced angina in Maastricht (SWAAM). A double blind randomised study. - SWAAM

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON36845

Enrollment

Registered

2007-05-04

Start date

2007-05-09

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic angina pectoris end stage coronary artery disease

Interventions

Patients will have 9 times a shockwave/placebo treatment. Every treatment takes about half an hour. One hour after treatment an ecg will be made.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Chronic angina pectoris CCS III or IV with documented reversible ischemia and/or hibernation patients demonstrates exercise tolerance time (ETT) duration 12 months

Exclusion criteria

Exclusion criteria: unstable angina pectoris haemodynamically significant valvular heart disease myocardial infarction

Design outcomes

Primary

Measure	Time frame
improvement of exercise tolerance	—

Secondary

Measure	Time frame
improvement of myocardial perfusion and improvement of quality of life	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)